Vitamin D in acute stress and critical illness

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 6, 2012, Pages 625-634

  Quraishi, Sadeq A ^a   Camargo, Carlos A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

25(OH)D; acute illness; critical care; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR; ZOLEDRONIC ACID;

ABSENTEEISM; ACUTE HEART INFARCTION; ACUTE STRESS; ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BLOOD VESSEL PERMEABILITY; CALCIUM ABSORPTION; CALCIUM METABOLISM; CALCIUM TRANSPORT; CARDIOPULMONARY BYPASS; CELL DIFFERENTIATION; CELL PROLIFERATION; COMMUNITY ACQUIRED PNEUMONIA; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE EXACERBATION; DRUG EFFECT; DRUG HALF LIFE; ENZYME ACTIVITY; HEMODILUTION; HORMONE RELEASE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMUNOMODULATION; INFLAMMATION; INFLUENZA; INTENSIVE CARE; KIDNEY TUBULE ABSORPTION; KNEE ARTHROSCOPY; MORTALITY; OSTEOLYSIS; PATIENT ASSESSMENT; PROTEIN BINDING; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SEASONAL VARIATION; STREPTOCOCCUS PNEUMONIA; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRAL UPPER RESPIRATORY TRACT INFECTION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ACUTE DISEASE; BIOLOGICAL MARKERS; CRITICAL ILLNESS; HUMANS; INFLAMMATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; STRESS, PHYSIOLOGICAL; VITAMIN D;

EID: 84868215849     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328358fc2b     Document Type: Review

References (85)

1. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169:626-632.
2. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168:1340-1349.
3. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52:1949-1956.
4. Lee JE. Circulating levels of vitamin D, vitamin D receptor polymorphisms, and colorectal adenoma: a meta-analysis. Nutr Res Pract 2011; 5:464-470.
5. Lin J, Manson JE, Lee I-M, et al. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 2007; 167:1050-1059.
6. Herr C, Greulich T, Koczulla RA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res 2011; 12:31.
7. Semba RD, Chang SS, Sun K, et al. Serum 25-hydroxyvitamin D and pulmonary function in older disabled community-dwelling women. J Gerontol A Biol Sci Med Sci 2011 [Epub ahead of print].
8. Vacek JL, Vanga SR, Good M, et al. Vitamin d deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2012; 109:359-363.
9. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85:1586-1591.
10. Laaksi I, Ruohola JP, Mattila V, et al. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 2010; 202:809-814.
11. Autier P, Gandini S. Vitamin D supplementation and total mortality: a metaanalysis of randomized controlled trials. Arch Intern Med 2007; 167:1730-1737.
12. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011; 7:CD007470.
13. de Paula FJA, Rosen CJ. Vitamin D safety and requirements. Arch Biochem Biophys 2011 [Epub ahead of print].
14. Lai JKC, Lucas RM, Clements MS, et al. Assessing vitamin D status: pitfalls for the unwary. Mol Nutr Food Res 2010; 54:1062-1071.
15. Heaney RP, Recker RR, Grote J, et al. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 2011; 96:E447-E452.
16. Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89:5387-5391.
17. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89:552-572.
18. Amrein K, Venkatesh B. Vitamin D and the critically ill patient. Curr Opin Clin Nutr Metab Care 2012; 15:188-193.
19. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53-58.
20. Holick MF. Vitamin D: a millenium perspective. J Cell Biochem 2003; 88:296-307.
21. Venkatesh B, Davidson B, Robinson K, et al. Do random estimations of vitamin D3 and parathyroid hormone reflect the 24-h profile in the critically ill? Intensive Care Med 2012; 38:177-179.
22. Passeri G, Pini G, Troiano L, et al. Low vitamin D status, high bone turnover, and bone fractures in centenarians. J Clin Endocrinol Metab 2003; 88:5109-5115.
23. Cashman KD, Kiely M. Towards prevention of vitamin D deficiency and beyond: knowledge gaps and research needs in vitamin D nutrition and public health. Br J Nutr 2011; 106:1617-1627.
24. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
25. Glendenning P, Inderjeeth CA. Screening for vitamin D deficiency: defining vitamin D deficiency, target thresholds of treatment and estimating the benefits of treatment. Pathology 2012; 44:160-165.
26. Biesalski HK. Vitamin D recommendations: beyond deficiency. Ann Nutr Metab 2011; 59:10-16.
27. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-1930.
28. Durazo-Arvizu RA, Dawson-Hughes B, Sempos CT, et al. Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. J Nutr 2010; 140:595-599.
29. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95:471-478.
30. Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011; 26:455-457.
31. Kulie T, Groff A, Redmer J, et al. Vitamin D: an evidence-based review. J Am Board Fam Med 2009; 22:698-706.
32. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 2011; 11:584-596.
33. White JH. Vitamin D metabolism and signaling in the immune system. Rev Endocr Metab Disord 2011 [Epub ahead of print].
34. Henry HL. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 2011; 25:531-541.
35. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011; 55:96-108.
36. Aranow C. Vitamin D and the immune system. J Investig Med 2011; 59:881-886.
37. Sigmundsdottir H. From the bench to the clinic: new aspects on immunoregulation by vitamin D analogs. Dermatoendocrinol 2011; 3:187-192.
38. White JH. Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection. Arch Biochem Biophys 2011 [Epub ahead of print].
39. Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med 2011; 11:325-335.
40. Mé ndez-Samperio P. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections. Peptides 2010; 31: 1791-1798.
41. Bhan I, Camargo CA, Wenger J, et al. Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults. J Allergy Clin Immunol 2011; 127:1302-1304; e1.
42. Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134:1129-1140.
43. White ANJ, Ng V, Spain CV, et al. Let the sun shine in: effects of ultraviolet radiation on invasive pneumococcal disease risk in Philadelphia, Pennsylvania. BMC Infect Dis 2009; 9:196.
44. Muhe L, Lulseged S, Mason KE, Simoes EA. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 1997; 349:1801-1804.
45. El-Radhi AS, Majeed M, Mansor N, Ibrahim M. High incidence of rickets in children with wheezy bronchitis in a developing country. J R Soc Med 1982; 75:884-887.
46. Ginde AA, Mansbach JM, Camargo CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169:384-390.
47. Berry DJ, Hesketh K, Power C, Hyppö nen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Brit J Nutr 2011; 106:1433-1440.
48. Sabetta JR, DePetrillo P, Cipriani RJ, et al. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE 2010; 5:e11088.
49. Laaksi I, Ruohola JP, Tuohimaa P, et al. An association of serum vitamin D concentrations 40nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 2007; 86:714-717.
50. Camargo CA, Ginde AA, Masbach JM. Vitamin D, childhood wheezing, asthma, and chronic obstructive pulmonary disease. In Feldman D, Pike JW, Adams JS, editors. Vitamin D. third ed. London, UK: Elsevier; 2011. pp. 2005-2006.
51. Lee JH, Gadi R, Spertus JA, et al. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol 2011; 107:1636-1638.
52. Wetmore JB, Gadi R, Lee JH, et al. Association of 25-hydroxyvitamin D deficiency with NT-pro BNP levels in patients with acute myocardial infarction: a cross-sectional analysis. BMC Res Notes 2011; 4:542.
53. Kelly D, Khan SQ, Thompson M, et al. Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction. Eur Heart J 2008; 29:2116-2124.
54. Zaloga GP, Chernow B. The multifactorial basis for hypocalcemia during sepsis. Ann Intern Med 1987; 107:36-41.
55. Nierman DM, Mechanick JI. Bone hyperresorption is prevalent in chronically critically ill patients. Chest 1998; 114:1122-1128.
56. Van den Berghe G, Van Roosbroeck D, Vanhove P, et al. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003; 88:4623-4632.
57. Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. N Engl J Med 2009; 360:191-1914.
58. Lee P, Nair P, Eisman JA, Center JR. Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality? Intensive Care Med 2009; 35:2028-2032.
59. Lucidarme O, Messai E, Mazzoni T, et al. Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study. Intensive Care Med 2010; 36:1609-1611.
60. Leow L, Simpson T, Cursons R, et al. Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology 2011; 16:611-616.
61. Annweiler C, Pochic S, Fantino B, et al. Serum vitamin D concentration and short-term mortality among geriatric inpatients in acute care settings. Adv Ther 2010; 27:245-249.
62. Venkatram S, Chilimuri S, Adrish M, et al. Vitamin D deficiency is associated with mortality in the medical intensive care unit. Crit Care 2011; 15:R292. Suggests association between 25(OH)D levels and mortality in critical illness.
63. Matthews LR, Ahmed Y, Wilson KL, et al. Worsening severity of vitamin D deficiency is associated with increased length of stay, surgical intensive care unit cost, and mortality rate in surgical intensive care unit patients. Am J Surg 2012 [Epub ahead of print].
64. Braun AB, Gibbons FK, Litonjua AA, et al. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med 2012; 40:63-72.
65. Arnson Y, Gringauz I, Itzhaky D, Amital H. Vitamin D deficiency is associated with poor outcomes and increased mortality in severely ill patients. Q J Med 2012 [Epub ahead of print].
66. Michos ED, Streeten EA, Ryan KA, et al. Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order Amish. Calcif Tissue Int 2009; 84:195-202.
67. Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm (Lond) 2008; 5:10.
68. Jorde R, Sneve M, Torjesen PA, et al. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 2010; 50:175-180.
69. Schleithoff SS, Zittermann A, Tenderich G, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a doubleblind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83:754-759.
70. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30:980-986.
71. Bjorkman M, Sorva A, Tilvis R. C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial. J Nutr Health Aging 2009; 13:435-439.
72. Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin d and C-reactive protein in asymptomatic adults (from the continuous national health and nutrition examination survey 2001 to 2006). Am J Cardiol 2012; 109:226-230.
73. Barth JH, Field HP, Mather AN, et al. Serum 25 hydroxy-vitamin D does not exhibit an acute phase reaction after acute myocardial infarction. Ann Clin Biochem 2012 [Epub ahead of print].
74. Bang UC, Novovic S, Andersen AM, et al. Variations in serum 25-hydroxyvitamin D during acute pancreatitis: an exploratory longitudinal study. Endocr Res 2011; 36:135-141.
75. Duncan A, Talwar D,McMillan DC, et al. Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am J Clin Nutr 2012; 95:64-71.
76. Bertoldo F, Pancheri S, Zenari S, et al. Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res 2010; 25:447-454.
77. Reid D, Toole BJ, Knox S, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 2011; 93:1006-1011.
78. Krishnan A, Ochola J, Mundy J, et al. Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Crit Care 2010; 14:R216.
79. Strampel W, Emkey R, Civitelli R. Safety considerations with bisphosphonates for the treatment of osteoporosis. Drug Saf 2007; 30:755-763.
80. Jeng L, Yamshchikov AV, Judd SE, et al. Alterations in vitamin D status and antimicrobial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009; 7:28.
81. Nykjaer A, Dragun D, Walther D, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999; 96:507-515.
82. Lee P. Vitamin D metabolism and deficiency in critical illness. Best Pract Res Clin Endocrinol Metab 2011; 25:769-781.
83. Kestenbaum B, Katz R, de Boer I, et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 2011; 58:1433-1441.
84. Flynn L, Zimmerman LH, McNorton K, et al. Effects of vitamin D deficiency in critically ill surgical patients. Am J Surg 2011; 203:379-382.
85. Mata-Granados JM, Vargas-Vasserot J, Ferreiro-Vera C, et al. Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LC-MS/MS method. J Steroid Biochem Mol Biol 2010; 121:452-455.